The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $71.69

Today's change0.00 0.00%
Updated December 19 4:04 PM EST. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $71.69

Today's change0.00 0.00%
Updated December 19 4:04 PM EST. Delayed by at least 15 minutes.

AstraZeneca PLC closed at (U.S.)$71.69.

Over the last five days, shares are unchanged, but have gained 20.75% over the last year to date. This security has outperformed the S&P 500 by 7.29% during the last year.

Key company metrics

  • Open(U.S.) $71.11
  • Previous close(U.S.) $71.69
  • High(U.S.) $72.06
  • Low(U.S.) $70.80
  • Bid / Ask-- / --
  • YTD % change+20.75%
  • Volume1,487,903
  • Average volume (10-day)2,422,462
  • Average volume (1-month)1,881,950
  • Average volume (3-month)2,054,232
  • 52-week range(U.S.) $58.29 to (U.S.) $82.68
  • Beta0.57
  • Trailing P/E88.23×
  • P/E 1 year forward16.17×
  • Forward PEG16.17×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield3.91%
  • Trailing EPS(U.S.) $0.81
Updated December 19 4:04 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue6,5426,4546,4166,844
Total other revenue--------
Total revenue6,5426,4546,4166,844
Gross profit5,1845,1735,0985,426
Total cost of revenue1,3581,2811,3181,418
Total operating expense6,0015,3455,5807,435
Selling / general / administrative2,7672,6502,4364,435
Research & development1,2751,2081,0981,345
Depreciation / amortization342267267--
Interest expense (income), net operating--------
Unusual expense (income)515417677385
Other operating expenses, total-256-478-216-148
Operating income5411,109836-591
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax322866638-715
Income after tax253797506-520
Income tax, total6969132-195
Net income254796504-524
Total adjustments to net income--------
Net income before extra. items254796504-524
Minority interest1-1-2-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items254796504-524
Inc. avail. to common incl. extra. items254796504-524
Diluted net income254796504-524
Dilution adjustment------0
Diluted weighted average shares1,2641,2641,2621,255
Diluted EPS excluding extraordinary itemsvalue per share0.200.630.40-0.42
Dividends per sharevalue per share0.000.900.001.90
Diluted normalized EPSvalue per share0.781.121.10-0.22